MGI
NAGE

Miller Global Investments’s Niagen Bioscience NAGE Stock Holding History

Miller Global Investments’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60K Hold
18,800
– – 0.05% 182
2026
Q1 		$82.9K Hold
18,800
– – 0.08% 163
2025
Q4 		$120K Buy
+18,800
New +$131K 0.11% 145

Other funds holding NAGE

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

Miller Global Investments's NAGE Position: Q2 2026 in Review

Miller Global Investments held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 18,800 shares worth $60K. The position accounts for 0.05% of the portfolio, ranked #182.

Miller Global Investments first reported a position in NAGE in Q4 2025 and has held it in 3 quarters since. The position peaked at $120K in Q4 2025. 34 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Miller Global Investments held 18,800 shares of Niagen Bioscience worth $60K as of Q2 2026.
  • Miller Global Investments left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up 0.05% of Miller Global Investments's portfolio in Q2 2026, its #182 holding.
  • Miller Global Investments first reported a position in Niagen Bioscience in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's Niagen Bioscience position peaked at $120K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.